KMDA

Kamada Ltd.

Price

$7.71

return (12m)

17.05%

p/e

20.19

p/bv

1.67

DIVIDEND YIELD

5.41%

KMDA price

Kamada

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment KMDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-5.97%

3 months

8.63%

1 year

17.05%

2 years

45.12%

5 years

41.43%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals KMDA

Valuation

P/E

20.19

Sector -3.10

Industry -3.10

P/BV

1.67

Sector 1.78

Industry 1.78

P/Revenue (PSR)

2.34

Sector 2.00

Industry 2.00

EV/EBITDA

8.81

Sector -202.91

Industry -202.91

EV/EBIT

13.68

Sector -40.75

Industry -40.75

P/EBITDA

10.44

Sector -19.52

Industry -19.52

P/EBIT

16.21

Sector -64.80

Industry -64.80

P/Total Assets

1.17

Sector 1.06

Industry 1.06

P/Net Current Assets

5.23

Sector -9.29

Industry -9.29

P/Working Capital

2.99

Sector -121.95

Industry -121.95

EPS

0.38

Sector -1.78

Industry -1.78

BVPS

4.66

Sector 2.01

Industry 2.01

Efficiency

Gross Margin

40.82%

Sector 41.24%

Industry 41.24%

EBITDA Margin

26.31%

Sector -21,194.51%

Industry -21,194.51%

EBIT Margin

14.51%

Sector -35.37%

Industry -35.37%

Net Profit Margins

11.60%

Sector -35.81%

Industry -35.81%

Asset Turnover

0.14

Sector 0.03

Industry 0.03

Profitability

ROE

8.25%

Sector -57.47%

Industry -57.47%

ROA

5.81%

Sector -59.48%

Industry -59.48%

ROIC

12.08%

Sector -1,878.27%

Industry -1,878.27%

Dividends

Dividend yield

5.41%

Sector -

Industry -

Payout

109.23%

Sector -

Industry -

Debt

Current Ratio

4.06

Sector 2.92

Industry 2.92

Net Debt / EBITDA

-1.63

Sector -19.80

Industry -19.80

Net Debt / EBIT

-2.53

Sector -4.14

Industry -4.14

Net Debt / Equity

-0.26

Sector -33,113.00

Industry -33,113.00

Gross Debt / Equity

0.00

Sector -0.84

Industry -0.84

Equity/Assets

0.70

Sector 0.46

Industry 0.46

Liabilities/Assets

0.30

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

13.11%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals KMDA

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Kamada ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$7.71

Fair Value

$6.31

Upside

-18.13%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
KMDA Kamada Ltd.	$7.71	17.05%	5.41%	20.19	1.67	8.25%	11.60%
PFE Pfizer Inc.	$30.44	36.07%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$295.11	35.26%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$39.80	-16.51%	4.76%	9.52	5.05	53.11%	35.32%
MRK Merck & Co. Inc.	$149.46	77.69%	2.34%	113.15	8.55	7.56%	4.77%
AZN AstraZeneca PLC	$187.27	15.68%	1.73%	22.38	5.77	27.27%	16.95%
ZTS Zoetis Inc.	$80.24	-43.19%	2.58%	12.83	10.75	83.77%	27.69%
AMGN Amgen Inc.	$469.71	66.32%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$912.86	40.12%	0.46%	19.24	2.63	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$130.85	100.51%	0.00%	35.61	102.60	288.13%	24.86%
MCK McKesson Corporation	$1,005.04	25.05%	0.34%	26.09	-31.01	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$559.48	34.10%	0.00%	30.31	6.59	21.76%	35.00%
CAH Cardinal Health Inc.	$253.37	55.51%	0.81%	34.72	-21.85	-62.92%	0.67%
ARGX argenx SE	$905.64	10.18%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.76	32.20%	0.00%	11.35	2.06	18.14%	18.88%
BIIB Biogen Inc.	$254.75	72.29%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KMDA - Historical Dividends

Current Dividend Yield

5.41%

5-year average Dividend Yield

2.96%

Current Payout

109.23%

5-year average Payout

41.61%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/26/2026	09/17/2026	0.17000000
Dividends	03/20/2026	04/06/2026	0.24960000
Dividends	03/14/2025	04/07/2025	0.20000000

ABOUT Kamada

Kamada Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

36 years

Founded: 1990

2013

Time since IPO - 13 years

408

Employees

Kamada Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $449.21 million, with shareholders equity totaling $269.56 million.

The company employs approximately 408 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kamada Ltd. reported $191.85 million in revenue, generating net income of $22.25 million.

Key financial metrics include a P/E ratio of 20.19, a price-to-book (P/B) ratio of 1.67, and a trailing twelve-month dividend yield of 5.41%.

The company trades under the ticker KMDA.

Market cap

$449.21 million

Net worth

$269.56 million

$269,558,000.00

Assets

$383.16 million

$383,162,000.00

Total Shares Outstanding

57.89 million

57,887,000

Average Daily Trading Volume

$134.42 Thousand

$134,416.22

Sector

Health Care

Industry

Biotechnology

KMDA

KMDA revenue and profits

Financial Results KMDA

DRAG THE FRAME TO SEE MORE DATA

KMDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$1,005.04 24,48% (12M)

P/E

26.09

0.34%

ROE

-118.84%

P/BV

-31.01

CAH - Cardinal Health

$253.37 34,07% (12M)

P/E

34.72

0.81%

ROE

-62.92%

P/BV

-21.85

ABBV - AbbVie

$295.11 39,67% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$149.46 78,93% (12M)

P/E

113.15

2.34%

ROE

7.56%

P/BV

8.55

AZN - AstraZeneca

$187.27 16,56% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.44 32,16% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$1,005.04 24,48% (12 M)

P/L

26.09

0.34%

ROE

-118.84%

P/VP

-31.01

CAH - Cardinal Health

$253.37 34,07% (12 M)

P/L

34.72

0.81%

ROE

-62.92%

P/VP

-21.85

ABBV - AbbVie

$295.11 39,67% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$149.46 78,93% (12 M)

P/L

113.15

2.34%

ROE

7.56%

P/VP

8.55

AZN - AstraZeneca

$187.27 16,56% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.44 32,16% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

Frequently Asked Questions

What is the price of Kamada (KMDA) today?

The current price of Kamada (KMDA) is $7.71. The stock began the year trading around $7.06 and is currently priced at $7.71. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Kamada (KMDA) pay dividends?

Kamada (KMDA) distributed dividends in the last year, in the months of April and September totaling $0.42. The Dividend Yield for the last 12 months is 5.41%.

Is Kamada (KMDA) a good investment?

Kamada (KMDA) is currently trading at $7.71 with a P/E ratio of 20.19. This represents a 586% premium compared to its historical average P/E. Over the past year, the stock paid $0.42 in dividends, resulting in a dividend yield of 5.41%. The total shareholder return over the same period was 17.05%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kamada (KMDA) stock?

You can buy Kamada (KMDA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KMDA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Kamada (KMDA) yield today?

Over the past month, Kamada (KMDA) has returned -5.97% — 17.05% over the past year, and 41.43% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.42 per share in dividends, resulting in a dividend yield of 5.41%.

If you were to purchase 100 shares of Kamada (KMDA) today at the current price of $7.71 your total investment would be $771.01.

Based on historical performance, the investment would have grown to approximately:

$902.47 after 1 year
$1,090.44 after 5 years
$771.01 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KMDA

Kamada Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KMDA

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING KMDA WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT Kamada

Kamada Ltd.

United States

36 years

2013

408

PROFIT X PRICE KMDA

Financial Results KMDA

KMDA cash flow

Asset, Revenue and Profit Growth - KMDA

KMDA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions